Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einar Gude

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Biomarkers in Medicine|February 14, 2014
Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levelsFinn Gustafsson, Einar Gude, Vilborg Sigurdardottir, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 13, 2024
[A man in his sixties with dyspnoea and systolic murmur after myocardial infarction]Joshua Ravindran, Eirik Hornes Halvorsen, Andreas Kongsvik, et al.
Scandinavian Cardiovascular Journal : SCJ|June 2, 2016
Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assistVinod Mishra, Arnt Eltvedt Fiane, Benny Adam Winsnes, et al.
Transplantation|September 14, 2018
Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE TrialArne K Andreassen, Kaspar Broch, Hans Eiskjær, et al.
Scandinavian Cardiovascular Journal : SCJ|September 2, 2011
Pregnancy in heart- and heart/lung recipients can be problematicMette Estensen, Einar Gude, Bjorn Ekmehag, et al.
American Heart Journal|August 25, 2009
The prognostic importance of modifiable risk factors after heart transplantationSatish Arora, Pål Aukrust, Arne Andreassen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 22, 2021
Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trialKristine V Brautaset Englund, Charlotte M Østby, Katrine Rolid, et al.
Clinical Transplantation|May 10, 2021
Prevalence of iron deficiency in heart transplant recipientsKristine V Brautaset Englund, Charlotte M Østby, Gry Tjønnås, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2017
The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patientsAnne Günther, Rune Andersen, Einar Gude, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 29, 2019
Heart failure with preserved ejection fractionOtto A Smiseth, Sverre E Kjeldsen, Øyvind Senstad Andersen, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Biomarkers in Medicine|February 14, 2014
Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levelsFinn Gustafsson, Einar Gude, Vilborg Sigurdardottir, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 13, 2024
[A man in his sixties with dyspnoea and systolic murmur after myocardial infarction]Joshua Ravindran, Eirik Hornes Halvorsen, Andreas Kongsvik, et al.
Scandinavian Cardiovascular Journal : SCJ|June 2, 2016
Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assistVinod Mishra, Arnt Eltvedt Fiane, Benny Adam Winsnes, et al.
Transplantation|September 14, 2018
Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE TrialArne K Andreassen, Kaspar Broch, Hans Eiskjær, et al.
Scandinavian Cardiovascular Journal : SCJ|September 2, 2011
Pregnancy in heart- and heart/lung recipients can be problematicMette Estensen, Einar Gude, Bjorn Ekmehag, et al.
American Heart Journal|August 25, 2009
The prognostic importance of modifiable risk factors after heart transplantationSatish Arora, Pål Aukrust, Arne Andreassen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 22, 2021
Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trialKristine V Brautaset Englund, Charlotte M Østby, Katrine Rolid, et al.
Clinical Transplantation|May 10, 2021
Prevalence of iron deficiency in heart transplant recipientsKristine V Brautaset Englund, Charlotte M Østby, Gry Tjønnås, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2017
The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patientsAnne Günther, Rune Andersen, Einar Gude, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 29, 2019
Heart failure with preserved ejection fractionOtto A Smiseth, Sverre E Kjeldsen, Øyvind Senstad Andersen, et al.
Pageof 10